Aethlon Medical Company

The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to address HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians.
Technology: Personalized Medicine
Industry: Precision Medicine
Headquarters: San Diego
Founded Date: 1999
Employees Number: 1-10
Funding Status: IPO

Visit Website
http://twitter.com/Aethlon_Medical
Register and Claim Ownership